AI assistant
Sending…
BICYCLE THERAPEUTICS PLC — Director's Dealing 2019
May 23, 2019
32777_dirs_2019-05-22_ddde9c47-c813-44b9-a5ff-e6df740ec2fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BICYCLE THERAPEUTICS Ltd (BCYC)
CIK: 0001761612
Period of Report: 2019-05-22
Reporting Person: Legault Pierre (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.10 | 2029-04-25 | Ordinary Shares (218312) | Direct |
Footnotes
F1: This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022.
F2: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.2723 to GBP 1.00 as of May 17, 2019.
More from BICYCLE THERAPEUTICS PLC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 17
Board/Management Information
2026
Mar 17
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 4
Board/Management Information
2026
Feb 3